​

Erasca (ERAS) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

ERAS Stock Forecast

Erasca (ERAS) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $5.50, with a high of $6.00 and a low of $5.00. This represents a 370.09% increase from the last price of $1.17.

$1 $2 $3 $4 $5 $6 High: $6 Avg: $5.5 Low: $5 Last Closed Price: $1.17

ERAS Stock Rating

Erasca stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

ERAS Price Target Upside V Benchmarks

TypeNameUpside
StockErasca370.09%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$5.00$5.00$5.50
Last Closing Price$1.17$1.17$1.17
Upside/Downside327.35%327.35%370.09%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2544---8
Mar, 2544---8
Feb, 2544---8
Jan, 25441--9
Dec, 24441--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 26, 2025Laura PrendergastRaymond James$5.00$1.48237.84%327.35%
Nov 18, 2024Maury RaycroftJefferies$6.00$2.40150.00%412.82%
Apr 01, 2024Chris ShibutaniGoldman Sachs$7.00$2.21216.74%498.29%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 26, 2025Raymond JamesOutperforminitialise
Nov 18, 2024JefferiesBuyinitialise
Aug 13, 2024H.C. WainwrightBuyBuyhold
May 20, 2024H.C. WainwrightBuyBuyhold
Apr 01, 2024Goldman SachsBuyBuyhold
Feb 03, 2023Morgan StanleyOverweightupgrade

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.83$-0.07----
Avg Forecast$-0.91$-0.74$-0.60$-0.64$-0.65$-0.54
High Forecast$-0.79$-0.70$-0.46$-0.52$-0.50$-0.54
Low Forecast$-1.20$-0.85$-0.72$-0.77$-0.76$-0.54
Surprise %-8.79%-90.54%----

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$817.84K$4.53M$26.59M$97.80M
High Forecast--$817.84K$4.53M$26.59M$97.80M
Low Forecast--$817.84K$4.53M$26.59M$97.80M
Surprise %------

Net Income Forecast

$-200M $-170M $-140M $-110M $-80M $-50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-125.04M$-161.65M----
Avg Forecast$-125.04M$-116.45M$-89.15M$-96.58M$-94.19M$-81.10M
High Forecast$-118.21M$-105.04M$-69.83M$-78.11M$-74.48M$-81.10M
Low Forecast$-180.19M$-127.87M$-108.47M$-115.04M$-113.91M$-81.10M
Surprise %-38.81%----

ERAS Forecast FAQ

Is Erasca stock a buy?

Erasca stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Erasca is a favorable investment for most analysts.

What is Erasca's price target?

Erasca's price target, set by 8 Wall Street analysts, averages $5.5 over the next 12 months. The price target range spans from $5 at the low end to $6 at the high end, suggesting a potential 370.09% change from the previous closing price of $1.17.

How does Erasca stock forecast compare to its benchmarks?

Erasca's stock forecast shows a 370.09% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Erasca over the past three months?

  • April 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Erasca’s EPS forecast?

Erasca's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.6, marking a 757.14% increase from the reported $-0.07 in 2024. Estimates for the following years are $-0.64 in 2026, $-0.65 in 2027, and $-0.54 in 2028.

What is Erasca’s revenue forecast?

Erasca's average annual revenue forecast for its fiscal year ending in December 2025 is $817.84K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $4.53M, followed by $26.59M for 2027, and $97.8M for 2028.

What is Erasca’s net income forecast?

Erasca's net income forecast for the fiscal year ending in December 2025 stands at $-89.151M, representing a -44.85% decrease from the reported $-162M in 2024. Projections indicate $-96.578M in 2026, $-94.193M in 2027, and $-81.1M in 2028.